Wim Hennink
Wim Hennink
Professor, Department of Pharmaceutics, Utrecht University, The Netherlands
Verified email at uu.nl
TitleCited byYear
Novel crosslinking methods to design hydrogels
WE Hennink, CF van Nostrum
Advanced drug delivery reviews 64, 223-236, 2012
20392012
Cationic polymer based gene delivery systems
SC De Smedt, J Demeester, WE Hennink
Pharmaceutical research 17 (2), 113-126, 2000
10132000
Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress
T Lammers, F Kiessling, WE Hennink, G Storm
Journal of controlled release 161 (2), 175-187, 2012
10092012
Reduction-sensitive polymers and bioconjugates for biomedical applications
F Meng, WE Hennink, Z Zhong
Biomaterials 30 (12), 2180-2198, 2009
9252009
25th anniversary article: engineering hydrogels for biofabrication
J Malda, J Visser, FP Melchels, T Jüngst, WE Hennink, WJA Dhert, J Groll, ...
Advanced materials 25 (36), 5011-5028, 2013
8582013
Hydrogels for protein delivery
T Vermonden, R Censi, WE Hennink
Chemical reviews 112 (5), 2853-2888, 2012
7872012
Protein instability in poly (lactic-co-glycolic acid) microparticles
M van de Weert, WE Hennink, W Jiskoot
Pharmaceutical research 17 (10), 1159-1167, 2000
7502000
Polymeric micelles in anticancer therapy: targeting, imaging and triggered release
C Oerlemans, W Bult, M Bos, G Storm, JFW Nijsen, WE Hennink
Pharmaceutical research 27 (12), 2569-2589, 2010
7312010
Theranostic nanomedicine
T Lammers, S Aime, WE Hennink, G Storm, F Kiessling
Accounts of chemical research 44 (10), 1029-1038, 2011
6742011
In situ gelling hydrogels for pharmaceutical and biomedical applications
SR Van Tomme, G Storm, WE Hennink
International journal of pharmaceutics 355 (1-2), 1-18, 2008
5602008
Tumour-targeted nanomedicines: principles and practice
T Lammers, WE Hennink, G Storm
British journal of cancer 99 (3), 392-397, 2008
5582008
Chitosan-based delivery systems for protein therapeutics and antigens
M Amidi, E Mastrobattista, W Jiskoot, WE Hennink
Advanced drug delivery reviews 62 (1), 59-82, 2010
5512010
Sheddable coatings for long-circulating nanoparticles
B Romberg, WE Hennink, G Storm
Pharmaceutical research 25 (1), 55-71, 2008
5352008
Identification of formaldehyde-induced modifications in proteins reactions with model peptides
B Metz, GFA Kersten, P Hoogerhout, HF Brugghe, HAM Timmermans, ...
Journal of Biological Chemistry 279 (8), 6235-6243, 2004
5352004
Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications
F Van De Manakker, T Vermonden, CF Van Nostrum, WE Hennink
Biomacromolecules 10 (12), 3157-3175, 2009
5242009
Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment
O Naksuriya, S Okonogi, RM Schiffelers, WE Hennink
Biomaterials 35 (10), 3365-3383, 2014
5162014
Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery
CJF Rijcken, O Soga, WE Hennink, CF Van Nostrum
Journal of controlled release 120 (3), 131-148, 2007
4732007
Biodegradable polymers as non-viral carriers for plasmid DNA delivery
J Luten, CF van Nostrum, SC De Smedt, WE Hennink
Journal of Controlled Release 126 (2), 97-110, 2008
4702008
Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives
GD Prestwich, DM Marecak, JF Marecek, KP Vercruysse, MR Ziebell
Journal of Controlled Release 53 (1-3), 93-103, 1998
4591998
Hydrogels in a historical perspective: From simple networks to smart materials
SJ Buwalda, KWM Boere, PJ Dijkstra, J Feijen, T Vermonden, ...
Journal of controlled release 190, 254-273, 2014
4312014
The system can't perform the operation now. Try again later.
Articles 1–20